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INTERLEUKIN 4 DRIVES 
PHYfOHEMAGGLUTININ-ACTIVATED T CELLS 
THROUGH SEVERAL CELL CYCLES: NO 
SYNERGISM BETWEEN INTERLEUKIN 2 AND 
INTERLEUKIN 4 
Thomas Lehrnbecher, 1 Hartmut Merz, 1 Walter Sebald, 1 Martin Pooe 
Cell kinetic studies of T cells stimulated with the interleukin 2 (11-2), D-4, or both 
lymphokines were performed with conventional [3H] thymidine incorporation and with the 
bivariate BrdU/Hoechst technique. 11-2 and 11-4 are able to drive phytohemagglutinin-
activated T cells through more than one cell cycle. Neither synergistic nor inhibitory efl'ect on 
T -cell proliferationwas seen for the stimulation with both 11-2 and 11-4 as compared with the 
effect ofll-2 alone. The quantitative data ofthe cell cycle distribution ofphytohemagglutinin-
activated T cells suggestthat the population ofll-4-responsive cells is at least an overlapping 
population, if not a real subset of the ·population of the 11-2-responsive cells. 
Copyright © 1991 by W.B. Saunders Company 
Interleukin 4 (Il-4) is a T cel1 and mast-celJ-derived 
polypeptide which was originally described as a B-eeil 
growth factor/ b:ut has recently been shown to have an 
array of biological effects on a variety of cell types.2 In 
addition, it is becoming evident that Il-4 participates in 
complex regulatory pathways with other lymphokines. 
11-4 seems to inhibit the 11-2-dependent generation of 
human lymphokine-activated killer cells3•4 and .II-2-
induced proliferation and differentiation of B cells and 
B-cell IinesY On the other hand, the II-4 enhancement 
of expression of major histocompatibility complex dass 
II antigen can be inhibited by gamma interferon.7 Il-4 
has also been shown to promote the proliferation of 
mitogen-activated human T cells.8'9' 10 Recent reports 
investigating the role of II-4 in Il-2-dependent re-
sponses have yielded discordant findings. 9•11•12 11-2 and 
Il-4 together supported a greater degree of prolifera-
tion of a number of human T -cell clones 12 and mitogen-
stimulated T cells9 than dic:l either lymphokine alone. 
In contrast, the addition of II-4 to cultures of T cells 
stimulated with low concentrations of both anti-CD3 
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monoclonal antiborlies (mAb) and 11-2 reduced the 
proliferation response. 11 
Most data about T-cell growth and prol.iferation 
stimulated with Il-2 or 11-4 are measurements .of the 
[ 3H]thymidine incorporation in different test sys-
tems. B·! 2 There. is very little infoimation available con-
ceming cell kinetics ofT cells stimulated with 11-2, Il-4, 
or the combination of Il-2 and 11-4. In this study, we 
apply a novel method for the examination of T-ceO 
proliferation which is based on incorporation of 
5-bromo-2' -deoxyuridine (BrdU) into the DNA of 
proliferating cells. The quenching of Hoechst 33258 
dye (Hoechst) fiuorescence allows to separate cells 
according to the number of cell cycles (CC) the cells 
traversed during the Observation period. The. unique 
attribute of this assay · is that it provides a clear 
distinction between different CC compartmeats of at 
least three consecutive CCs. In this study, we investi-
gate the proliferation kinetics of activated T cells with 
Il-2, Il-4, or the combination-of 11-2 and Il-4 in view of a 
putative synergism between the lymphokin6s. 
RESULTS 
The proliferative response of phyt-ohemagglutinin 
(PHA)-activated T cells was measured- by means of 
(3H]thymidine incorporation (Fig. 1). Without the 
addition of any lymphokine, PHA-activated · T cells 
show only a weak incorporation of · eH)thymidine. 
Stimulation of the PHA-activated T cells with Il-2 or 
with the combinatioh oft"Il-2 and 11-4 gave similar 
results. After 24, 48, and 72. h, [3H]thymidine uptake 
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was comparable for both stimulative regimes. Neither a 
significant additive nor an inhibitory effect was seen for 
the combination of both lymphokines as compared 
with 11-2 alone. The [3H]thymidine uptake afforded by 
11-4 alone was approximately one third ofthat by Il-2 or 
the combination of Il-2 and 11-4 for each observed time 
period. 
These results were confirmed both by the detec-
tion of PH]thymidine incorporation by means of in situ 
autoradiography and by a nonradioactive in situ detec-
tion, which allows a monitaring of proliferating cells 
through incorporation of the thymidine analogue BrdU 
and subsequent localization using a specific mono-
clonal antibody. Both methods gave comparable results 
(data not shown). 
The proliferative response of activated T cells was 
examined in more detail by using continuous bromo-
deoxyuridine labeling followed by Hoechst/ethidium 
bromide flow cytometry. Figure 2 shows representative 
cytograms of cultures exposed to the type of interleu-
kin indicated for 72 h. The abscissa represents Hoechst 
fluorescence (blue ), which is quenched if BrdU is 
incorporated during S phasetraverse of cells, whereas 
the ordinate shows BrdU-insensitive ethidium bromide 
fluorescence (red). Each dot represents an individual 
cell; clusters arise where cells with similar fluorescence 
intensity concur. 
In the untreated control culture, all cells remained 
in the resting state (labeled as GO/Gl). In contrast, the 
panel showing the cytogram of the 11-2-treated culture 
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Figure l. [3H]Thymidine in· 
corporation in PHA-activated T 
cells. 
T cells are stimulated with (A) 
no lymphokine, (B) 11-2 (200 
U), (C) 11-4 (200 U), and (D) 
11-2 (200 U) and 11-4 (200 U) for 
24, 48, or 72 h. 
shows few cells in the GO/Gl duster. Most cells reside 
in a dusterIeft from the GO/G1 duster (labeled Gl'). 
These cells underwent one round of BrdU incorpora-
tion during S phase and halved their DNA content 
aftertraverse of the G2 compartment of the cell cycle. 
The trail moving to the right side and up from the G1' 
duster represents cells passing through a second S 
phase (labeled S') and a second G2 phase (G2'). Due 
to the bifiliary BrdU Substitution, this trail no Ionger 
moves to the left, but still some additional quenching of 
Hoechst fluorescence is afforded during the second 
cycle S phase. Cells that underwent a second mitosis 
during 72 h of culture appear to the left of the G 1' 
duster in a duster Iabeled G1". Also, a few signals 
representing cells in the S phase of the third cycle can 
be seen. The panel representing a culture exposed to 
11-4 shows a less elaborate picture: most cells are 
retained in the GO/Gl duster and a few reached the 
second and third cycle Gl phase (01' and G1", 
respectively). The combination of 11-2 and ll-4lead to a 
cytogram roughly similar to that of the 11-2 exposed 
culture. 
Quantification of the data obtained of the cultures 
stimulated with 11-2, 11-4, or both for 24, 48, or 72 h is 
shown in Table 1. These data are corrected for the 
number of cell divisions a given cell has undergone and 
exclude the population of dead cells or dying cells. 
Table 1 shows calculations for the first, second, and 
third CC. 
Without the addition of either Il-2 or 11-4, all the 
Figure 2. Bivariate Hoechst/ 
ethidium bromide cytogram of 
PHA-activated cell cultures con· 
tinuously labelcd with 100 J.LM 
BrdU in the presence of the 
indicated interleukins. 
Control IL-2 
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The abscissa displays BrdU-
quenched Hoechst fluores-
cence, whereas the ordinate 
shows unquenched ethidium 
bromide fluorescence. The first 
cycle compartments are labeled 
GO/G1, S, G2; the second cycle 
compartments G 1', S', G2', and 
the third cycle compartments 
GI" and S''. 
BrdU/Hoechst Fluorescence 
PHA-activated T cells rest in the GO/G1 phase of the 
first CC. After 24 h with Il-2, 11-4, or both, about 99% 
of the cells remain in the first cell cycle. With either 11-2 
or the combination of 11-2 and Il-4, approximately 20% 
of the cells enter the S phase of the first CC, whereas 
this was seen only by 9.2% of cells stimulated with 11-4 
alone. None of the cells leave Gl' (G1 phase of the 
second CC) when exposed for 24 h to the lymphokines. 
After 48 h with 11-4 alone, 89.9% of the cells 
remain in the GO/Gl phase of the first CC whereas 
3.3% of the cells leave the first CC but are arrested in 
G 1 '. With II-2 or the combination of both lymphokines, 
approximately 25% ofthe cells remain in GO/Gl ofthe 
first CC, approximately 40% of the cells are in the 
second CC, and < 2% are already in the third CC. Of 
the 40% of cells in the second CC, about half enter the 
S phase. 
When exposed for 72 h to 11-4, the majority of cells 
still remain in GO/Gl of the first CC. Approximately 
12.7% of the ce1ls leave the first CC to enter the second 
and only 1.2% leave the second CC to enter the third 
CC, but there are no cells in the S phase of the third 
CC. Thus, a total of 21.6% of cells stimulated with 11-4 
alone undergo one or two divisions in the first 72 h 
after addition of the lymphokine. In contrast, stimu-
lated with Il-2 or with the combination of 11-2 and 11-4, 
TABLE 1. Cell cycle distribution of PHA·activated T cells stimulated with the indicated interleukins. 
First CC Second CC ThirdCC 
GO/Gl s G2 GO/GI G2 GO/GI G2 
24h 
Control 100 0 0 0 0 0 0 0 0 
11-2 73.3 22.4 2.7 1.6 0 0 0 0 0 
11-4 90.2 9.2 0 0.6 0 0 0 0 0 
11-2/Il-4 78.6 19.2 0.7 1.5 0 0 0 0 0 
48h 
Control 100 0 0 0 0 0 0 0 0 
11-2 24.3 22.5 8.7 24.8 14.7 2.7 2.3 0 0 
Il-4 89.9 6.7 0.1 3.3 0 0 0 0 0 
Il-2/11-4 27.1 27.6 6.8 23.2 12.2 1.8 1.3 0 0 
72h 
Control 100 0 0 0 0 0 0 0 0 
Il-2 13.2 5.9 5.9 26.4 23.8 4 17.1 3.6 0.1 
Il-4 78.4 7.5 0.2 10.1 2.2 0.4 1.2 0 0 
11-2/11-4 14.6 7.2 7.5 30.2 16.4 6.6 12.9 4.4 0.2 
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over 70% of cells are capable of entering the second or 
third CC (three times more cells than stimulated with 
11-4 alone). Approximately 14% of cells are still in 
GO/G1 of the first CC, whereas 54.2% and 53.2%, 
respectively, enter the second CC and 20.8% and 
17.5%, respectively, enter the third CC. With Il-2 or 
the combination of both Il-2 and 11-4, approximately 
4% of the cells undergo three divisions, whereas with 
Il-4 alone none of the cells could divide more than 
twice. 
DISCUSSION 
The stimulatory effect of the lymphokines 11-2 and 
11-4 on activation and proliferation of T cells can be 
examined with unprecedented precision by the bivari-
ate BrdU /Hoechst technique. The number of noncyc-
ling cells can be analyzed at various time points after 
activation, and among the cycling cell fraction, one can 
distinguish at least three sequential rounds of DNA 
synthesis. Moreover, the distribution of cells through-
out individual CC compartments and accumulation of 
cells in single compartments can be ascertained. 
T-cell proliferation is mostly investigated by 
[3H]thymidine incorporation. Our preliminary data 
show that detection of proliferating cells by iticorpora-
tion of [3H]thymidine and by incorporation of the 
thymidine analogue BrdU gives comparable results. 
Limite'd data conceming cell kinetics ofT cells stimu-
lated with Il-2, Il-4, or tlie combination ofboth lympho-
kines · are now available. Thus, with the bivariate 
BrdU /Hoechst analysis, new aspects concerning the 
11-2 or IJ-4 effects on CC progression of T cells are 
revealed. 11-2 and 11-4 as well can drive tlie PHA-
activated T cells through one and more CCs and not 
only to the S or G2 phase of the first CC. When 
exposed 72 h to Il-4, nearly 80% cells are secluded in 
GO/G1 ofthe first CC, but more than 10% ofthe cells 
are found in the second and more than 1% are found in 
the third CC. In contrast, after 72 h with either Il-2 
alone or n~2 and 11-4 combined, only about 25% of the 
cells remain in the first CC, whereas approximately 
55% of the cells have entered the second and 20% of 
the cells have entered the third CC. In our test system, 
because 11-2 is shown to drive many more cells through 
the CCs than 11-4 and because there was no additive 
effect of the two lymphokines, one is tempted to 
conclude that the population 11-4 responsive cells is at 
least an overlapping, if not a real subset of the 
population of the Il-2 ~;;esponsive cells; this means that 
in our test system, aB or most Il-4 responders are also 
11-2 responders, whereas only some Il-2 responders are 
also Il-4 resp.onders. This finding would be compatible 
with recent reports sh9wing that, in the mouse system, 
11-4.can act as an analogue of 11-2 on some or all T 
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cells13 and that most human T-cell clones selected in 
Il-2 arealso able to respond to 11-4. 10 
In this study, the simultaneaus stimulation of 
PHA-activated T cells with both 11-2 and 11-4 shows 
neither an inhibitory nor a synergistic effect in compar-
ison to 11-2 alone. Furthermore, the combination of 
both lymphokines exerts a stronger effect on prolifera-
tion of T cells than 11-4 alone. 11-2 is a more potent 
stimulating factor on T cells than 11-4. These results 
obtained in the [3H]thymidine assay are confirmed in 
the CC compartment analysis where there was a 
similar pattern of the distribution of T cells in the 
different CC compartments for the Stimulation with 
either 11-2 alone or the combination of both Il-2 and 
11-4. 
Recently, discordant findings of lymphokine-
dependent proliferation of T cells were reported. 
Habetswallner et al. 14 reported that simultaneaus addi-
tion of 11-2 and 11-4 did not result in an additive or 
synergistic effect on T -cell proliferation to either lym-
phokine alone. In contrast, Mitchell et al.9 described 
that 11-2 and Il-4 combined support a greater degree of 
proliferation than Il-2 or Il-4 alone. Martinez et al. 11 
observed that Il-4 enhanced the proliferation ofT cells 
already activated by anti-CD3 mAb and Il-2. On the 
other band, when T cells were cultured with anti-CD3 
mAb, 11-2, and 11-4 simultaneously, the proliferation 
response was diminished as compared with that of 
anti-CD3 mAb and 11-2 alone. 11 The addition of 11-4 
also inhibits 11-2-induced proliferation in all lympho-
cyte population.15 
· All these data suggest that the proliferation of T 
cells is critically dependent on the test system which 
includes the nature and intensity of the stimulus, the 
preactivation of the cells, and the time point and the 
period of the addition of the different lymphokines. I t 
is presently unclearwhich Subpopulations ofT cells are 
Il-2 responders and which are 11-4 responders. For 
further investigations on the lymphokine-induced T-cell 
proliferation, BrdU /Hoechst flow cytometry may pro-
vide a very informative tool. 
MATERIALS AND MEmODS 
Interleukins 
The 11-2 and Il-4 preparations were Escherichia coli-
produced Il-2 and Il-4. The biological activity of 11-2 was 
deterrnined by using PH]thymidine incorporation into an 
11-2-dependent rnurine T -cellline ( CTLL-2; A TCC MB214 ). 16 
T cells activated with PHA for 7 days and then incubated 
with 11-4 for 72 h, were used to deterrnine the biological 
activity of 11-4 using [3H)thymidine incotporation (rnodified 
accordinglyB). One unit is the amount of rll-2 or rll-4 that 
provides a signal 50% of that elicited by saturating amounts 
of lymphokine. 
Preparation of PHA Activated T Cells 
Peripheral blood mononuclear cells (PBMC) from nor-
mal individuals were separated by Ficoll-Hypaque density 
gradient centrifugation. PBMC were cultured in RPMI 1640 
medium (Gibco, Grand lsland, NY) with 10% fetal calf 
serum (FCS, Gibco) (1 x 107 cells/mL) in the presence of 2 
J.Lg/mL phytohemagglutinin HA-15 (Wellcome, Research 
Triangle Park, NC) in a humid athmosphere with 5% C02 at 
37°C for 7 days. 
t H]Thymidine Incorporation Assay 
The PHA-activated T cells were extensively washed, 
then 1 x 105 cells were placed in a 96-well ftat-bottom plate 
and cultured in 200 p.L of RPMI 1640 containing 10% FCS in 
the presence of the recombinant lymphokines 11-2, 11-4, or of 
both for 24, 48, or 72 h. The culture was then pulsed with 0.5 
J.LCi [3H]thymidine (Amersham Corp., Arlington Heights, 
IL) for the last 6 h and then harvested onto glassfiber filters 
(Scatron, Oslo, Norway). The radioactivity was counted by 
liquid scintillation. All data are indicated as the mean counts 
per minute of at least triplicate cultures. 
Bromodeoxyuridine Labeling 
PHA-activated T cells were exposed to the interleukins 
as described above, and concomitantly the culture medium 
was supplemented with 100 J.LM of BrdU and deoxycytidine. 
All culture plates were carefully wrapped in aluminum foil to 
avoid exposure to light of short wavelengths. After 24, 48, or 
72 h of culture, cells were harvested under illumination with 
red light only. Until analysis, cells were stored in the dark at 
- 20oc in culture medium Supplement with 10% FCS and 
10% dimethylsulfoxide. 
Cell Staining and Flow Cytometry 
After thawing, cell pellets were resuspended in a stain-
ing buffer containing 1.2 f.Lg of Hoechst 33258 and 2.0 f.lg of 
ethidium bromide per milliliter of buffer. 17•18 Flow cytometric 
analysis was perfonned with an epiillumination system of 
conventional design (ICP 22, Ortho Diagnostic Systems, 
Raritan, NJ) equipped with a mercury arc Iamp (HBO 100, 
Osram, Berlin, Germany). Bivariate cytograms of Hoechst 
and ethidium bromide ftuorescence were digitalized and 
recorded with a PDP 11/23 microcomputer (Digital Equip-
ment Corporation, Maynard, MA). Cells betonging to three 
successive CCs can be distinguished due to BrdU quenching 
of Hoechst ftuorescence. 17-19 By electronic selection of the 
signal clusters representing each CC, rotation, and deconvo-
lution, conventional CC distributions were obtained, which 
were fitted with a standard CC algorithm (Phoenix Flow 
System, San Diego, CA). The cell numbers in each CC were 
normalized to the percentage of original cells by correcting 
for the numbers of cell divisions by which cells originated. 
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